GCG and obesity due to melanocortin 4 receptor deficiency: This systematic review aimed to evaluate existing comparative studies regarding the impact of semaglutide compared to another GLP-1 RA (liraglutide and efinopegdutide) in facilitating weight reduction and safety profile in patients with obesity [5].